A cutting-edge imaging strategy could significantly improve survival rates among patients at risk for liver cancer.
Cirrhosis of the Liver
Hepatitis C rates have surged in the U.S. as drug use and opioid abuse have risen. A Michigan Medicine hepatologist reflects on the troubling trend.
Rapid rise in liver deaths highlights new challenges in treatment and prevention despite gains in fighting hepatitis C, researchers say.
A new review of private insurance data finds that alcohol is a major contributor to cirrhosis cases — and that women drinkers are disproportionately af
A new review suggests it’s time to road test the point-of-care screening tools doctors use to identify brain dysfunction in patients with advanced liver disease.